Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations
Clinical trial NCT00943943 · COMPLETED
Trial details
- NCT number
- NCT00943943
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-29
- Primary completion
- 2017-03-23
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.